Economic evaluation and epidemic modelling

Research theme leads

Engineer futuristic screen

About this theme

This research theme addresses two key components of health protection evaluation: identifying the impact of interventions on incidence, prevalence and prevention of infection; and determining the intervention components or programmes which represent cost-effective control of infection.

Research areas

Viral hepatitis - intervention development and prevention

Our research focuses on the development and evaluation of prevention and treatment interventions to reduce the transmission and health consequences of the Hepatitis B (HBV) and Hepatitis C (HCV) viruses. We use modelling and health economic models to evaluate the impact and cost-effectiveness of new, existing and emerging interventions based on existing evidence and specific cost and outcome data collected for key interventions from a range of sites in UK and Globally.

Designing optimal control programmes for meningococcal disease

We use mathematical and health economic models to understand how best to prevent the transmission and health consequences of meningococcal disease, which is a leading cause of death in young children in the UK and can leave survivors with disabling complications.

Mathematical modelling to support tuberculosis control and interventions in England

Controlling TB is one of Public Health England's top priorities. We are assessing how multi-faceted tuberculosis (TB) control measures, including swift diagnosis and contact tracing, can be improved. 

We also provide expertise in modelling and economic evaluation for responsive research projects.

STI modelling

Our work aims to understand how best to use new technologies, such as rapid diagnostic tests or vaccines, to control sexually transmitted infections to obtain value for money.

Research examples


A comparison of the cost of different methods of re-testing chlamydia positive individuals in England

Analysis of the potential for point-of-care tests to enable individualised treatment of infections caused by antimicrobial resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study

Cost-effectiveness of different interventions to improve the testing and linkage to care for people with Hepatitis C


Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling

 Research team

Bristol Infectious Disease Dynamics Group

 Find out more about the University of Bristol Infectious Disease Dynamics research group.